# An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)

> **NCT00092677** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1873 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DRUG:** ezetimibe (+) simvastatin
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00092677
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 1873 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092677, "An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00092677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*